The application of high-throughput screening to novel lead discovery
- 1 January 1998
- book chapter
- Published by Springer Nature
- Vol. 51, 245-269
- https://doi.org/10.1007/978-3-0348-8845-5_7
Abstract
The ability to discover new lead compounds for novel therapeutic targets is a pivotal step in drug discovery programmes. High-throughput screening (HTS) utilises a number of platforms for the rapid screening of novel targets to accelerate this process. Key issues in HTS include assay configuration and the ability of a high-throughput screen to predict drug-target interactions accurately. This review highlights a number of issues in the HTS process and describes three key target areas that are likely to be sources of novel, therapeutically important drugs. Particular emphasis is placed on the mechanistic basis of drug-target interactions that are of prime importance in the design of HTS approaches. Critical aspects of information management related to HTS are summarised.Keywords
This publication has 38 references indexed in Scilit:
- Inverse agonism: pharmacological curiosity or potential therapeutic strategy?Published by Elsevier ,2000
- Evaluation of a CRE-Directed Luciferase Reporter Gene Assay as an Alternative to Measuring cAMP AccumulationSLAS Discovery, 1997
- Searching for Chemokine Receptor Binding Antagonists by High Throughput ScreeningSLAS Discovery, 1997
- High Throughput Screening Using Fully Integrated Robotic ScreeningSLAS Discovery, 1997
- Utilization of the ORCA to Completely Automate Scintillation Proximity AssaysSLAS Discovery, 1996
- High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian CellsBasic & Clinical Pharmacology & Toxicology, 1995
- Structural basis of ion channel permeation and selectivityCurrent Opinion in Neurobiology, 1994
- The Patch Clamp TechniqueScientific American, 1992
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptorBiochemistry, 1987